RS Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

RS Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$46.7M	Sell	2,154,390 -1,024,017	-32%	-$18.3M	0.48%	58
2016 Q1	$47.6M	Sell	3,178,407 -596,652	-16%	-$10M	0.47%	69
2015 Q4	$82.7M	Sell	3,775,059 -312,592	-8%	-$5.83M	0.74%	32
2015 Q3	$64.5M	Buy	4,087,651 +486,397	+14%	+$7.8M	0.57%	55
2015 Q2	$51.4M	Buy	3,601,254 +1,123,680	+45%	+$19M	0.44%	81
2015 Q1	$42.9M	Buy	2,477,574 +176,532	+8%	+$3.12M	0.38%	96
2014 Q4	$41.3M	Buy	2,301,042 +94,614	+4%	+$1.52M	0.37%	100
2014 Q3	$29M	Buy	2,206,428 +489,100	+28%	+$6.59M	0.27%	130
2014 Q2	$24.7M	Buy	+1,717,328	New	+$22.4M	0.21%	158

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

RS Investment Management's NXTM Position: Q2 2016 in Review

RS Investment Management reduced its NxStage Medical Inc. (NXTM) stake by 32% in Q2 2016, selling an estimated $18.3M and leaving 2,154,390 shares worth $46.7M. The position accounts for 0.48% of the portfolio, ranked #58.

RS Investment Management first reported a position in NXTM in Q2 2014 and has held it in 9 quarters since. The position peaked at $82.7M in Q4 2015. 147 funds tracked by Wall St. Rank hold NXTM as of Q2 2016.

RS Investment Management held 2,154,390 shares of NxStage Medical Inc. worth $46.7M as of Q2 2016.
RS Investment Management sold 1,024,017 NxStage Medical Inc. shares in Q2 2016, an estimated $18.3M.
NxStage Medical Inc. made up 0.48% of RS Investment Management's portfolio in Q2 2016, its #58 holding.
RS Investment Management first reported a position in NxStage Medical Inc. in Q2 2014 and has held it in 9 quarters since.
RS Investment Management's NxStage Medical Inc. position peaked at $82.7M in Q4 2015.
147 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.